
APDN, Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program
April 7th, 2021
APDN, Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program
April 7th, 2021
Securing Each Dose: Reducing Risk with Dosage Level Authentication
April 1st, 2021
‘Tag, Test and Track’ is the Future of Supply Chain Authentication
April 1st, 2021
APDN Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development
April 1st, 2021
An interview with Dr. James Hayward, Chairman, President & CEO
March 29th, 2021
APDN Receives Purchase Order for 10,000 Linea™ COVID-19 Assay Kits
March 11th, 2021
Applied DNA Sciences Industry Chat
March 10th, 2021
Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel
March 9th, 2021
Applied DNA to Participate in Upcoming Conferences
March 8th, 2021